| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 12.89% | UBS | $66 → $54 | Maintains | Neutral |
| 11/09/2023 | 67.24% | Truist Securities | $84 → $80 | Maintains | Buy |
| 11/09/2023 | 31.7% | Piper Sandler | $74 → $63 | Maintains | Overweight |
| 11/09/2023 | 129.96% | Benchmark | $115 → $110 | Maintains | Buy |
| 11/07/2023 | 50.52% | Keybanc | $81 → $72 | Maintains | Overweight |
| 09/13/2023 | 75.6% | Truist Securities | → $84 | Reiterates | Buy → Buy |
| 08/28/2023 | 37.97% | UBS | $72 → $66 | Maintains | Neutral |
| 08/23/2023 | 69.33% | Keybanc | $82 → $81 | Maintains | Overweight |
| 08/21/2023 | 75.6% | Truist Securities | → $84 | Reiterates | Buy → Buy |
| 08/10/2023 | 67.24% | JP Morgan | $85 → $80 | Maintains | Overweight |
| 08/10/2023 | 46.34% | Oppenheimer | $75 → $70 | Maintains | Outperform |
| 08/10/2023 | 140.41% | Benchmark | $120 → $115 | Maintains | Buy |
| 08/10/2023 | 134.14% | Credit Suisse | $123 → $112 | Maintains | Outperform |
| 08/10/2023 | 44.25% | Citigroup | $71 → $69 | Maintains | Buy |
| 08/10/2023 | 56.79% | Barclays | $85 → $75 | Maintains | Overweight |
| 08/07/2023 | 71.42% | Keybanc | $72 → $82 | Maintains | Overweight |
| 05/30/2023 | 50.52% | Keybanc | $65 → $72 | Maintains | Overweight |
| 05/18/2023 | 67.24% | Jefferies | $70 → $80 | Maintains | Buy |
| 05/12/2023 | 48.43% | Citigroup | $64 → $71 | Maintains | Buy |
| 05/12/2023 | 65.15% | Wells Fargo | $70 → $79 | Maintains | Overweight |
| 05/11/2023 | 157.13% | Credit Suisse | $120 → $123 | Maintains | Outperform |
| 05/11/2023 | 83.97% | Truist Securities | $85 → $88 | Maintains | Buy |
| 05/11/2023 | 27.52% | UBS | $54 → $61 | Maintains | Neutral |
| 05/11/2023 | 56.79% | Oppenheimer | $70 → $75 | Maintains | Outperform |
| 05/11/2023 | 77.69% | Barclays | $75 → $85 | Maintains | Overweight |
| 05/03/2023 | 33.79% | Citigroup | $67 → $64 | Maintains | Buy |
| 02/15/2023 | 46.34% | Jefferies | $65 → $70 | Maintains | Buy |
| 02/15/2023 | 54.7% | Piper Sandler | $67 → $74 | Maintains | Overweight |
| 02/15/2023 | 12.89% | UBS | $46 → $54 | Upgrades | Sell → Neutral |
| 02/15/2023 | 54.7% | Goldman Sachs | $83 → $74 | Maintains | Buy |
| 02/15/2023 | 46.34% | Oppenheimer | → $70 | Reiterates | → Outperform |
| 02/15/2023 | 150.86% | Benchmark | $130 → $120 | Maintains | Buy |
| 02/15/2023 | 56.79% | Barclays | $70 → $75 | Maintains | Overweight |
| 02/15/2023 | 150.86% | Credit Suisse | $108 → $120 | Maintains | Outperform |
| 02/13/2023 | 40.06% | Citigroup | $60 → $67 | Maintains | Buy |
| 02/10/2023 | 171.77% | Benchmark | → $130 | Reiterates | → Buy |
| 01/19/2023 | 46.34% | Wells Fargo | $85 → $70 | Maintains | Overweight |
| 12/13/2022 | 25.43% | Citigroup | → $60 | Initiates Coverage On | → Buy |
| 12/02/2022 | -3.84% | UBS | → $46 | Initiates Coverage On | → Sell |
| 11/10/2022 | 81.88% | Goldman Sachs | $115 → $87 | Maintains | Buy |
| 11/10/2022 | 46.34% | Barclays | $125 → $70 | Maintains | Overweight |
| 11/10/2022 | 125.78% | Credit Suisse | $101 → $108 | Maintains | Outperform |
| 11/10/2022 | 40.06% | Piper Sandler | $100 → $67 | Maintains | Overweight |
| 11/03/2022 | 111.14% | Credit Suisse | $121 → $101 | Maintains | Outperform |
| 10/12/2022 | 88.15% | Jefferies | → $90 | Maintains | Buy |
| 10/07/2022 | 67.24% | JP Morgan | $95 → $80 | Maintains | Overweight |
| 08/11/2022 | 152.95% | Credit Suisse | $127 → $121 | Maintains | Outperform |
| 08/11/2022 | 159.22% | Cowen & Co. | $130 → $124 | Maintains | Outperform |
| 08/11/2022 | 161.31% | Barclays | $130 → $125 | Maintains | Overweight |
| 08/11/2022 | 140.41% | Goldman Sachs | $133 → $115 | Maintains | Buy |
| 08/11/2022 | 109.05% | Piper Sandler | $110 → $100 | Maintains | Overweight |
| 06/14/2022 | 171.77% | Cowen & Co. | $150 → $130 | Maintains | Outperform |
| 06/10/2022 | 178.04% | Goldman Sachs | $137 → $133 | Maintains | Buy |
| 05/18/2022 | 182.22% | Wells Fargo | $165 → $135 | Maintains | Overweight |
| 05/12/2022 | 196.85% | BMO Capital | $154 → $142 | Maintains | Outperform |
| 05/11/2022 | 182.22% | Oppenheimer | $155 → $135 | Maintains | Outperform |
| 05/11/2022 | 171.77% | Barclays | $160 → $130 | Maintains | Overweight |
| 05/11/2022 | 165.5% | Credit Suisse | $167 → $127 | Maintains | Outperform |
| 05/11/2022 | 129.96% | Piper Sandler | $145 → $110 | Maintains | Overweight |
| 04/11/2022 | 244.94% | Keybanc | $190 → $165 | Maintains | Overweight |
| 02/22/2022 | 261.66% | BMO Capital | $195 → $173 | Maintains | Outperform |
| 02/17/2022 | 249.12% | Credit Suisse | $161 → $167 | Maintains | Outperform |
| 02/17/2022 | 203.13% | Piper Sandler | $168 → $145 | Maintains | Overweight |
| 11/08/2021 | 286.75% | Truist Securities | $180 → $185 | Maintains | Buy |
| 11/08/2021 | 236.57% | Credit Suisse | $155 → $161 | Maintains | Outperform |
| 11/04/2021 | 297.2% | Barclays | $150 → $190 | Maintains | Overweight |
| 11/04/2021 | 286.75% | Keybanc | $189 → $185 | Maintains | Overweight |
| 10/07/2021 | 295.11% | Keybanc | $277 → $189 | Maintains | Overweight |
| 08/11/2021 | 234.48% | Wells Fargo | $280 → $160 | Maintains | Overweight |
| 08/06/2021 | 224.03% | Credit Suisse | $201 → $155 | Maintains | Outperform |
| 07/21/2021 | 255.39% | BMO Capital | $250 → $170 | Upgrades | Market Perform → Outperform |
| 06/11/2021 | 276.29% | Piper Sandler | $278 → $180 | Maintains | Overweight |
| 06/04/2021 | 318.1% | Truist Securities | $255 → $200 | Maintains | Buy |
| 05/27/2021 | — | BTIG | Downgrades | Buy → Neutral | |
| 05/26/2021 | 303.47% | Wedbush | $276 → $193 | Maintains | Outperform |
| 05/10/2021 | 479.07% | Keybanc | $276 → $277 | Maintains | Overweight |
| 04/30/2021 | 508.34% | Credit Suisse | $253 → $291 | Maintains | Outperform |
| 03/23/2021 | 476.98% | Keybanc | $265 → $276 | Maintains | Overweight |
| 02/09/2021 | 495.8% | Citigroup | $162 → $285 | Maintains | Buy |
| 02/05/2021 | 453.99% | Deutsche Bank | $230 → $265 | Maintains | Buy |
| 02/05/2021 | 447.72% | Wedbush | $237 → $262 | Maintains | Outperform |
| 02/05/2021 | 453.99% | Cowen & Co. | $240 → $265 | Maintains | Outperform |
| 02/05/2021 | 453.99% | Oppenheimer | $210 → $265 | Maintains | Outperform |
| 02/05/2021 | 422.63% | Truist Securities | $200 → $250 | Maintains | Buy |
| 02/05/2021 | 464.44% | Barclays | $163 → $270 | Maintains | Overweight |
| 02/05/2021 | 458.17% | Piper Sandler | $240 → $267 | Maintains | Overweight |
| 02/01/2021 | 428.9% | Credit Suisse | $208 → $253 | Maintains | Outperform |
| 01/14/2021 | 380.82% | Deutsche Bank | $165 → $230 | Maintains | Buy |
| 12/23/2020 | 265.84% | BMO Capital | → $175 | Downgrades | Outperform → Market Perform |
| 12/23/2020 | 339.01% | Keybanc | $165 → $210 | Maintains | Overweight |
| 11/09/2020 | 244.94% | Keybanc | $160 → $165 | Maintains | Overweight |
| 09/25/2020 | 203.13% | Piper Sandler | → $145 | Initiates Coverage On | → Overweight |
| 09/15/2020 | 234.48% | Keybanc | → $160 | Initiates Coverage On | → Overweight |
| 08/19/2020 | 244.94% | Citigroup | $145 → $165 | Maintains | Buy |
| 08/19/2020 | 234.48% | Credit Suisse | $92 → $160 | Maintains | Outperform |
| 08/18/2020 | 263.75% | BMO Capital | $171 → $174 | Maintains | Outperform |
| 08/12/2020 | 192.67% | Truist Securities | $135 → $140 | Maintains | Buy |
| 07/27/2020 | 224.03% | Jefferies | $150 → $155 | Maintains | Buy |
| 07/20/2020 | 203.13% | Citigroup | $81.38 → $145 | Maintains | Buy |
| 07/17/2020 | 215.67% | Deutsche Bank | $327 → $151 | Maintains | Buy |
| 07/13/2020 | 209.4% | B of A Securities | $381 → $148 | Maintains | Buy |
| 06/23/2020 | 671.4% | BMO Capital | $316 → $369 | Maintains | Outperform |
| 06/23/2020 | 589.87% | SunTrust Robinson Humphrey | $275 → $330 | Maintains | Buy |
| 06/11/2020 | 589.87% | BTIG | → $330 | Initiates Coverage On | → Buy |
| 06/02/2020 | 583.6% | Deutsche Bank | $290 → $327 | Maintains | Buy |
| 05/11/2020 | 474.89% | Oppenheimer | $265 → $275 | Maintains | Outperform |
| 05/11/2020 | 560.6% | BMO Capital | $272 → $316 | Maintains | Outperform |
| 05/08/2020 | 474.89% | SunTrust Robinson Humphrey | $227 → $275 | Maintains | Buy |
| 05/08/2020 | 485.35% | Credit Suisse | $283 → $280 | Maintains | Outperform |
| 05/08/2020 | 575.24% | Nomura | $296 → $323 | Maintains | Buy |
| 05/08/2020 | 531.34% | UBS | $282 → $302 | Maintains | Buy |
| 04/21/2020 | 489.53% | UBS | $308 → $282 | Maintains | Buy |
| 04/20/2020 | 518.79% | Nomura | $304 → $296 | Maintains | Buy |
| 04/14/2020 | 401.72% | Citigroup | $285 → $240 | Maintains | Buy |
| 04/02/2020 | 418.45% | SunTrust Robinson Humphrey | $267 → $248 | Maintains | Buy |
| 02/10/2020 | 535.52% | Nomura | $285 → $304 | Maintains | Buy |
| 02/10/2020 | 458.17% | SunTrust Robinson Humphrey | $270 → $267 | Maintains | Buy |
| 01/28/2020 | 506.25% | Barclays | $254 → $290 | Maintains | Overweight |
| 01/17/2020 | 548.06% | UBS | $290 → $310 | Maintains | Buy |
| 12/23/2019 | 516.7% | Wedbush | → $295 | Initiates Coverage On | → Outperform |
| 11/12/2019 | 464.44% | Guggenheim | $300 → $270 | Maintains | Buy |
| 11/11/2019 | 495.8% | Nomura | $314 → $285 | Maintains | Buy |
| 11/11/2019 | 527.16% | BMO Capital | $320 → $300 | Maintains | Outperform |
| 11/08/2019 | 435.17% | Credit Suisse | $284 → $256 | Maintains | Outperform |
| 11/08/2019 | 430.99% | Barclays | $260 → $254 | Maintains | Overweight |
| 11/08/2019 | 506.25% | UBS | $296 → $290 | Maintains | Buy |
| 11/08/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 10/16/2019 | 518.79% | UBS | $300 → $296 | Maintains | Buy |
| 10/14/2019 | 663.04% | B of A Securities | $340 → $365 | Maintains | Buy |
| 09/17/2019 | 506.25% | Citigroup | → $290 | Initiates Coverage On | → Buy |
| 08/09/2019 | 550.15% | Barclays | $295 → $311 | Maintains | Overweight |
| 08/09/2019 | 453.99% | SunTrust Robinson Humphrey | $250 → $265 | Maintains | Buy |
| 08/09/2019 | 548.06% | Oppenheimer | $285 → $310 | Maintains | Outperform |
| 08/09/2019 | 527.16% | Guggenheim | → $300 | Upgrades | Neutral → Buy |
| 08/09/2019 | 556.42% | Nomura | $282 → $314 | Maintains | Buy |
| 08/09/2019 | 493.71% | Credit Suisse | $263 → $284 | Maintains | Outperform |
| 08/09/2019 | 568.97% | BMO Capital | $319 → $320 | Maintains | Outperform |
| 05/13/2019 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 05/13/2019 | 489.53% | Nomura | $239 → $282 | Maintains | Buy |
| 05/10/2019 | 495.8% | UBS | $265 → $285 | Maintains | Buy |
| 05/10/2019 | 516.7% | B of A Securities | $273 → $295 | Maintains | Buy |
| 02/11/2019 | 508.34% | BMO Capital | $287 → $291 | Maintains | Outperform |
| 02/11/2019 | 399.63% | Nomura | $206 → $239 | Maintains | Buy |
| 02/11/2019 | 408% | Credit Suisse | $231 → $243 | Maintains | Outperform |
| 02/04/2019 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 01/08/2019 | 376.64% | B of A Securities | $240 → $228 | Reiterates | Buy → Buy |
| 12/19/2018 | 395.45% | SunTrust Robinson Humphrey | → $237 | Initiates Coverage On | → Buy |
| 11/29/2018 | — | Macquarie | Initiates Coverage On | → Outperform |
What is the target price for IAC (IAC)?
The latest price target for IAC (NASDAQ: IAC) was reported by UBS on November 17, 2023. The analyst firm set a price target for $54.00 expecting IAC to rise to within 12 months (a possible 12.89% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IAC (IAC)?
The latest analyst rating for IAC (NASDAQ: IAC) was provided by UBS, and IAC maintained their neutral rating.
When is the next analyst rating going to be posted or updated for IAC (IAC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IAC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IAC was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating IAC (IAC) correct?
While ratings are subjective and will change, the latest IAC (IAC) rating was a maintained with a price target of $66.00 to $54.00. The current price IAC (IAC) is trading at is $47.84, which is out of the analyst's predicted range.